This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Are Bullish on These Healthcare Stocks: Viking Therapeutics (VKTX), Bio-Techne (TECH)

Tipranks - Tipranks - Fri Jun 26, 10:28AM CDT

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Viking Therapeutics (VKTX) and Bio-Techne (TECH) with bullish sentiments.

TipRanks' Prime Week Sale - 70% Off

Viking Therapeutics (VKTX)

Maxim Group analyst Naz Rahman reiterated a Buy rating on Viking Therapeutics today and set a price target of $70.00. The company’s shares closed last Thursday at $38.84.

According to TipRanks.com, Rahman is ranked 0 out of 5 stars with an average return of -6.9% and a 36.6% success rate. Rahman covers the Healthcare sector, focusing on stocks such as Galmed Pharmaceuticals, Xtant Medical Holdings, and Vertex Pharmaceuticals. ;'>

Viking Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $92.91, which is a 144.5% upside from current levels. In a report released yesterday, Raymond James also maintained a Buy rating on the stock.

See Insiders’ Hot Stocks on TipRanks >>

Bio-Techne (TECH)

William Blair analyst Matt Larew maintained a Buy rating on Bio-Techne today. The company’s shares closed last Thursday at $70.47.

According to TipRanks.com, Larew is a 4-star analyst with an average return of 7.0% and a 52.4% success rate. Larew covers the Healthcare sector, focusing on stocks such as Maravai Lifesciences Holdings, West Pharmaceutical Services, and Ginkgo Bioworks Holdings. ;'>

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Bio-Techne with a $59.89 average price target, a -14.7% downside from current levels. In a report released today, TipRanks – PerPlexity also upgraded the stock to Buy with a $67.00 price target.

Read More on VKTX:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).